nach oben

Erschienen in:

25.12.2017

Management of acute heart failure in adult patients with congenital heart disease

verfasst von: Alexander Van De Bruaene, Lukas Meier, Walter Droogne, Pieter De Meester, Els Troost, Marc Gewillig, Werner Budts

Erschienen in: Heart Failure Reviews | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Heart failure is an increasing reason for hospitalization and the leading cause of death in patients with adult congenital heart disease (ACHD). Recently, the European Society of Cardiology and the American Heart Association published consensus documents on the management of chronic heart failure in ACHD patients. However, little data and/or guidelines are available for the management of (sub)acute heart failure. The ACHD population is heterogeneous by definition and often has complex underlying anatomy, which could pose a challenge to the physician confronted with the ACHD patient in (sub)acute heart failure. Recognizing the underlying anatomy and awareness of the possible complications related would result in better treatment, avoid unnecessary delays, and improve outcomes of the ACHD patient with (sub)acute heart failure. This review focuses on the management of (sub)acute heart failure in ACHD with specific attention to lesion-specific issues.

Moons P, Bovijn L, Budts W, Belmans A, Gewillig M (2010) Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 122(22):2264–2272. https://doi.org/10.1161/CIRCULATIONAHA.110.946343 PubMedCrossRef

Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD (2001) Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 37(5):1170–1175. https://doi.org/10.1016/S0735-1097(01)01272-4 PubMedCrossRef

Bolger AP, Gatzoulis MA (2004) Towards defining heart failure in adults with congenital heart disease. Int J Cardiol 97(Suppl 1):15–23. https://doi.org/10.1016/j.ijcard.2004.08.005 PubMedCrossRef

Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, Babu-Narayan S, Wort SJ, Dimopoulos K, Gatzoulis MA. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015

Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, Plokker HW, Grobbee DE, Mulder BJ (2010) The emerging burden of hospital admissions of adults with congenital heart disease. Heart 96(11):872–878. https://doi.org/10.1136/hrt.2009.185595 PubMedCrossRef

Mackie AS, Pilote L, Ionescu-Ittu R, Rahme E, Marelli AJ (2007) Health care resource utilization in adults with congenital heart disease. Am J Cardiol 99(6):839–843. https://doi.org/10.1016/j.amjcard.2006.10.054 PubMedCrossRef

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) Authors/Task Force M. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200. https://doi.org/10.1093/eurheartj/ehw128 PubMedCrossRef

Burchill LJ, Redington AN, Silversides CK, Ross HJ, Jimenez-Juan L, Mital S, Oechslin EN, Dragulescu A, Slorach C, Mertens L, Wald RM (2015) Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation. Int J Cardiol 197:209–215. https://doi.org/10.1016/j.ijcard.2015.06.018 PubMedCrossRef

Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA (2002) Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1):92–99. https://doi.org/10.1161/01.CIR.0000020009.30736.3F PubMedCrossRef

10.

Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, Poole-Wilson PA, Coats AJ, Gatzoulis MA, Anker SD (2003) Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 92(2):188–193. https://doi.org/10.1016/S0002-9149(03)00536-8 PubMedCrossRef

11.

Mou SS, Haudek SB, Lequier L, Pena O, Leonard S, Nikaidoh H, Giroir BP, Stromberg D (2002) Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med 30(4):827–832. https://doi.org/10.1097/00003246-200204000-00018 PubMedCrossRef

12.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847PubMedCrossRef

13.

Budts W, Roos-Hesselink J, Radle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, Crespo-Leiro MG, Walker F, Frogoudaki AA (2016) Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 37(18):1419–1427. https://doi.org/10.1093/eurheartj/ehv741 PubMedPubMedCentralCrossRef

14.

Welke KF, Morris CD, King E, Komanapalli C, Reller MD, Ungerleider RM (2007) Population-based perspective of long-term outcomes after surgical repair of partial atrioventricular septal defect. Ann Thorac Surg 84(2):624–628; discussion 628-9. https://doi.org/10.1016/j.athoracsur.2007.03.079 PubMedCrossRef

15.

De Meester P, Buys R, Van De Bruaene A, Gabriels C, Voigt JU, Vanhees L, Herijgers P, Troost E, Budts W (2014) Functional and haemodynamic assessment of mild-to-moderate pulmonary valve stenosis at rest and during exercise. Heart 100(17):1354–1359. https://doi.org/10.1136/heartjnl-2014-305627 PubMedCrossRef

16.

Voet A, Rega F, de Bruaene AV, Troost E, Gewillig M, Van Damme S, Budts W (2012) Long-term outcome after treatment of isolated pulmonary valve stenosis. Int J Cardiol 156(1):11–15. https://doi.org/10.1016/j.ijcard.2010.10.038 PubMedCrossRef

17.

Kim HW, Seo DM, Shin HJ, Park JJ, Yoon TJ (2011) Long term results of right ventricular outflow tract reconstruction with homografts. Korean J Thorac Cardiovasc Surg 44(2):108–114. https://doi.org/10.5090/kjtcs.2011.44.2.108 PubMedPubMedCentralCrossRef

18.

Wood P (1958) The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 2(5099):755–762. https://doi.org/10.1136/bmj.2.5099.755 PubMedPubMedCentralCrossRef

19.

Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W (2002) Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39(7):1214–1219. https://doi.org/10.1016/S0735-1097(02)01744-8 PubMedCrossRef

20.

Diller GP, Dimopoulos K, Kafka H, Yen HS, Gatzoulis MA (2007) Model of chronic adaptation: right ventricular function in Eisenmenger syndrome. Eur Heart J Suppl 9(suppl_H):H54–H60. https://doi.org/10.1093/eurheartj/sum019 CrossRef

21.

Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA (2006) Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 27(14):1737–1742. https://doi.org/10.1093/eurheartj/ehl116 PubMedCrossRef

22.

Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, McLaughlin PR, Siu SC (1999) Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 84(6):677–681. https://doi.org/10.1016/S0002-9149(99)00415-4 PubMedCrossRef

23.

Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S (1998) Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19(12):1845–1855. https://doi.org/10.1053/euhj.1998.1046 PubMedCrossRef

24.

Van De Bruaene A, De Meester P, Voigt JU, Delcroix M, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiery JL, Paelinck B, Morissens M, Budts W (2012) Right ventricular function in patients with Eisenmenger syndrome. Am J Cardiol 109(8):1206–1211. https://doi.org/10.1016/j.amjcard.2011.12.003 CrossRef

25.

Schuuring MJ, van Riel AC, Vis JC, Duffels MG, van Dijk AP (2015) de Bruin-Bon RH, Zwinderman AH, Mulder BJ, Bouma BJ. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study. Int J Cardiol 181:270–276. https://doi.org/10.1016/j.ijcard.2014.11.222 PubMedCrossRef

26.

Gewillig M, Brown SC, Eyskens B, Heying R, Ganame J, Budts W, La Gerche A, Gorenflo M (2010) The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 10(3):428–433. https://doi.org/10.1510/icvts.2009.218594 PubMedCrossRef

27.

Gewillig M (2005) Ventricular dysfunction of the functionally univentricular heart: management and outcomes. Cardiol Young 15(Suppl 3):31–34. https://doi.org/10.1017/S1047951105001605 PubMedCrossRef

28.

Cordina R, von Klemperer K, Kempny A, West C, Senior R, Celermajer DS, Gatzoulis MA, Babu-Narayan SV, Li W (2017) Echocardiographic predictors of mortality in adults with a Fontan circulation. JACC Cardiovasc Imaging 10(2):212–213. https://doi.org/10.1016/j.jcmg.2016.03.006 PubMedCrossRef

29.

Cheung YF, Penny DJ, Redington AN (2000) Serial assessment of left ventricular diastolic function after Fontan procedure. Heart 83(4):420–424. https://doi.org/10.1136/heart.83.4.420 PubMedPubMedCentralCrossRef

30.

Gewillig MH, Lundstrom UR, Deanfield JE, Bull C, Franklin RC, Graham TP Jr, Wyse RK (1990) Impact of Fontan operation on left ventricular size and contractility in tricuspid atresia. Circulation 81(1):118–127. https://doi.org/10.1161/01.CIR.81.1.118 PubMedCrossRef

31.

Cheung MM, Smallhorn JF, McCrindle BW, Van Arsdell GS, Redington AN (2005) Non-invasive assessment of ventricular force-frequency relations in the univentricular circulation by tissue Doppler echocardiography: a novel method of assessing myocardial performance in congenital heart disease. Heart 91(10):1338–1342. https://doi.org/10.1136/hrt.2004.048207 PubMedPubMedCentralCrossRef

32.

Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM, Nicolson SC, Spray TL (2002) Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg 123(2):237–245. https://doi.org/10.1067/mtc.2002.119337 PubMedCrossRef

33.

Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G (1997) Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg 114(3):392–403; discussion 404-5. https://doi.org/10.1016/S0022-5223(97)70184-3 PubMedCrossRef

34.

Ho SY (2009) Anatomy and myoarchitecture of the left ventricular wall in normal and in disease. Eur J Echocardiogr 10:iii3–iii7PubMedCrossRef

35.

Roche SL, Redington AN (2013) The failing right ventricle in congenital heart disease. Can J Cardiol 29(7):768–778. https://doi.org/10.1016/j.cjca.2013.04.018 PubMedCrossRef

36.

Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL (2000) Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 36:255–261PubMedCrossRef

37.

Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, Albert DC, Goncalves A, Murtra M, Casaldaliga J (2005) Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart 91(5):652–656. https://doi.org/10.1136/hrt.2003.029769 PubMedPubMedCentralCrossRef

38.

Moons P, Gewillig M, Sluysmans T, Verhaaren H, Viart P, Massin M, Suys B, Budts W, Pasquet A, De Wolf D, Vliers A (2004) Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart 90(3):307–313. https://doi.org/10.1136/hrt.2002.007138 PubMedPubMedCentralCrossRef

39.

Helsen F, De Meester P, Van Keer J, Gabriels C, Van De Bruaene A, Herijgers P, Rega F, Meyns B, Gewillig M, Troost E, Budts W (2015) Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries. Int J Cardiol 196:1–6. https://doi.org/10.1016/j.ijcard.2015.05.142 PubMedCrossRef

40.

Allwork SP, Bentall HH, Becker AE, Cameron H, Gerlis LM, Wilkinson JL, Anderson RH (1976) Congenitally corrected transposition of the great arteries: morphologic study of 32 cases. Am J Cardiol 38(7):910–923. https://doi.org/10.1016/0002-9149(76)90804-3 PubMedCrossRef

41.

Pettersen E, Helle-Valle T, Edvardsen T, Lindberg H, Smith HJ, Smevik B, Smiseth OA, Andersen K (2007) Contraction pattern of the systemic right ventricle shift from longitudinal to circumferential shortening and absent global ventricular torsion. J Am Coll Cardiol 49(25):2450–2456. https://doi.org/10.1016/j.jacc.2007.02.062 PubMedCrossRef

42.

Derrick GP, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN (2000) Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation 102(19 Suppl 3):III154–III159PubMed

43.

van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ (2013) Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation 127(3):322–330. https://doi.org/10.1161/CIRCULATIONAHA.112.135392 PubMedCrossRef

44.

Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, Marcotte F, Mercier LA (2005) Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 112(16):2411–2416. https://doi.org/10.1161/CIRCULATIONAHA.105.543470 PubMedCrossRef

45.

Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD (2008) Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int J Cardiol 129(2):187–192. https://doi.org/10.1016/j.ijcard.2008.04.056 PubMedCrossRef

46.

Murray CD (1926) The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 12(3):207–214. https://doi.org/10.1073/pnas.12.3.207 PubMedPubMedCentralCrossRef

47.

Glenny RW (2011) Emergence of matched airway and vascular trees from fractal rules. J Appl Physiol 110(4):1119–1129. https://doi.org/10.1152/japplphysiol.01293.2010 PubMedCrossRef

48.

Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ (2007) Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 120(2):198–204. https://doi.org/10.1016/j.ijcard.2006.09.017 PubMedCrossRef

49.

Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E, Gatzoulis MA, Mulder BJ (2007) Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart 93(6):682–687. https://doi.org/10.1136/hrt.2006.098848 PubMedCrossRef

50.

Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ (2010) Mortality in adult congenital heart disease. Eur Heart J 31(10):1220–1229. https://doi.org/10.1093/eurheartj/ehq032 PubMedCrossRef

51.

Egbe AC, Connolly HM, Niaz T, Yogeswaran V, Taggart NW, Qureshi MY, Poterucha JT, Khan AR, Driscoll DJ (2017) Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation. Am Heart J 183:10–17. https://doi.org/10.1016/j.ahj.2016.09.014 PubMedCrossRef

52.

Egbe AC, Connolly HM, McLeod CJ, Ammash NM, Niaz T, Yogeswaran V, Poterucha JT, Qureshi MY, Driscoll DJ (2016) Thrombotic and embolic complications associated with atrial arrhythmia after Fontan operation: role of prophylactic therapy. J Am Coll Cardiol 68(12):1312–1319. https://doi.org/10.1016/j.jacc.2016.06.056 PubMedCrossRef

53.

Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J (2003) Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 42(11):1982–1987. https://doi.org/10.1016/j.jacc.2003.07.022 PubMedCrossRef

54.

Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, Gatzoulis MA (2007) Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 50(7):634–642. https://doi.org/10.1016/j.jacc.2007.04.056 PubMedCrossRef

55.

Van De Bruaene A, La Gerche A, Prior DL, Voigt J-U, Delcroix M, Budts W. Pulmonary vascular resistance as assessed by bicycle stress echocardiography in patients with ASD type secundum. Circulation: Cardiovascular Imaging

56.

Inglessis I, Landzberg MJ (2007) Interventional catheterization in adult congenital heart disease. Circulation 115(12):1622–1633. https://doi.org/10.1161/CIRCULATIONAHA.105.592428 PubMedCrossRef

57.

Srivastava D, Preminger T, Lock JE, Mandell V, Keane JF, Mayer JE Jr, Kozakewich H, Spevak PJ (1995) Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 92(5):1217–1222. https://doi.org/10.1161/01.CIR.92.5.1217 PubMedCrossRef

58.

Kuijpers JM, Koolbergen DR, Groenink M, Peels KC, Reichert CL, Post MC, Bosker HA, Wajon EM, Zwinderman AH, Mulder BJ, Bouma BJ. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 38(26):2048–2056. https://doi.org/10.1093/eurheartj/ehw591

59.

Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff DE, Heying R, Frerich S, Vanagt WY, Troost E, Gewillig M (2015) Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart 101(10):788–793. https://doi.org/10.1136/heartjnl-2014-306761 PubMedCrossRef

60.

Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, Nakazawa M (2008) Japanese Society of Pediatric C, Cardiac S. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 101(1):114–118. https://doi.org/10.1016/j.amjcard.2007.07.054 PubMedCrossRef

61.

Schmitt HJ, Schuetz WH, Proeschel PA, Jaklin C (1993) Accuracy of pulse oximetry in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 7(1):61–65. https://doi.org/10.1016/1053-0770(93)90120-A PubMedCrossRef

62.

Baggen VJ, van den Bosch AE, Eindhoven JA, Schut AW, Cuypers JA, Witsenburg M, de Waart M, van Schaik RH, Zijlstra F, Boersma E, Roos-Hesselink JW (2017) Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin-T, and growth-differentiation factor 15 in adult congenital heart disease. Circulation 135(3):264–279. https://doi.org/10.1161/CIRCULATIONAHA.116.023255 PubMedCrossRef

63.

Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, Davos C, Swan L, Gatzoulis MA (2010) Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 105(6):869–873. https://doi.org/10.1016/j.amjcard.2009.11.041 PubMedCrossRef

64.

Van De Bruaene A, Hickey EJ, Kovacs AH, Crean AM, Wald RM, Silversides CK, Redington AN, Ross HJ, Alba AC, Billia F, Nair K, Benson L, Horlick E, Osten M, Colman J, Heggie J, Oechslin EN, Roche SL (2017) Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.Int J Cardiol. https://doi.org/10.1016/j.ijcard.2017.10.086.

65.

Gewillig M, Wyse RK, de Leval MR, Deanfield JE (1992) Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences. Br Heart J 67(1):72–79. https://doi.org/10.1136/hrt.67.1.72 PubMedPubMedCentralCrossRef

66.

Reich JD, Auld D, Hulse E, Sullivan K, Campbell R (1998) The pediatric radiofrequency ablation registry’s experience with Ebstein’s anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol 9(12):1370–1377. https://doi.org/10.1111/j.1540-8167.1998.tb00113.x PubMedCrossRef

67.

Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN (2000) Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356(9234):975–981. https://doi.org/10.1016/S0140-6736(00)02714-8 PubMedCrossRef

68.

Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S (2004) Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 44(5):1095–1102. https://doi.org/10.1016/j.jacc.2004.05.073 PubMedCrossRef

69.

Eyskens B, Mertens L, Moerman P, Ector H, Daenen W, Gewillig M (1997) Cardiac strangulation, a rare complication of epicardial pacemaker leads during growth. Heart 77(3):288–289. https://doi.org/10.1136/hrt.77.3.288 PubMedPubMedCentralCrossRef

70.

Frescura C, Basso C, Thiene G, Corrado D, Pennelli T, Angelini A, Daliento L (1998) Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol 29(7):689–695. https://doi.org/10.1016/S0046-8177(98)90277-5 PubMedCrossRef

71.

Taylor AJ, Rogan KM, Virmani R (1992) Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol 20(3):640–647. https://doi.org/10.1016/0735-1097(92)90019-J PubMedCrossRef

72.

Raisky O, Bergoend E, Agnoletti G, Ou P, Bonnet D, Sidi D, Vouhe PR (2007) Late coronary artery lesions after neonatal arterial switch operation: results of surgical coronary revascularization. Eur J Cardiothorac Surg 31(5):894–898. https://doi.org/10.1016/j.ejcts.2007.02.003 PubMedCrossRef

73.

Pillutla P, Shetty KD, Foster E (2009) Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005. Am Heart J 158(5):874–879. https://doi.org/10.1016/j.ahj.2009.08.014 PubMedCrossRef

74.

Bhatt AB, Foster E, Kuehl K, Alpert J, Brabeck S, Crumb S, Davidson WR Jr, Earing MG, Ghoshhajra BB, Karamlou T, Mital S, Ting J, Tseng ZH (2015) Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation 131(21):1884–1931. https://doi.org/10.1161/CIR.0000000000000204 PubMedCrossRef

75.

Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ (2010) Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 14(5):R169. https://doi.org/10.1186/cc9264 PubMedPubMedCentralCrossRef

76.

Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM (2015) Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 131(24):2143–2150. https://doi.org/10.1161/CIRCULATIONAHA.114.014494 PubMedCrossRef

77.

Park JH, Balmain S, Berry C, Morton JJ, McMurray JJ (2010) Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 96(7):533–538. https://doi.org/10.1136/hrt.2009.175257 PubMedCrossRef

78.

Delcroix M, Naeije R (2010) Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev 19(117):204–211. https://doi.org/10.1183/09059180.00004910 PubMedCrossRef

79.

Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52(3):200–207. https://doi.org/10.1016/j.jacc.2008.02.083 PubMedCrossRef

80.

Apitz C, Honjo O, Friedberg MK, Assad RS, Van Arsdell G, Humpl T, Redington AN (2012) Beneficial effects of vasopressors on right ventricular function in experimental acute right ventricular failure in a rabbit model. Thorac Cardiovasc Surg 60(1):17–23. https://doi.org/10.1055/s-0031-1298058 PubMedCrossRef

81.

Apitz C, Honjo O, Humpl T, Li J, Assad RS, Cho MY, Hong J, Friedberg MK, Redington AN (2012) Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload. J Thorac Cardiovasc Surg 144(6):1494–1501. https://doi.org/10.1016/j.jtcvs.2012.06.027 PubMedCrossRef

82.

Hyldebrandt JA, Agger P, Siven E, Wemmelund KB, Heiberg J, Frederiksen CA, Ravn HB (2015) Effects of milrinone and epinephrine or dopamine on biventricular function and hemodynamics in right heart failure after pulmonary regurgitation. Am J Physiol Heart Circ Physiol 309(5):H860–H866. https://doi.org/10.1152/ajpheart.00384.2015 PubMed

83.

Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002. https://doi.org/10.1161/01.CIR.0000051365.81920.28 PubMedCrossRef

84.

Smith AH, Owen J, Borgman KY, Fish FA, Kannankeril PJ (2011) Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias. Am J Cardiol 108(11):1620–1624. https://doi.org/10.1016/j.amjcard.2011.07.023 PubMedPubMedCentralCrossRef

85.

Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, Naeije R, Brimioulle S (2004) Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 32(4):1035–1040. https://doi.org/10.1097/01.CCM.0000120052.77953.07 PubMedCrossRef

86.

Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering C (2002) Investigators of the Levosimendan Infusion versus Dobutamine S. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196–202. https://doi.org/10.1016/S0140-6736(02)09455-2 PubMedCrossRef

87.

Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE (2012) Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Med 38(7):1198–1204. https://doi.org/10.1007/s00134-012-2564-6 PubMedCrossRef

88.

Bhorade S, Christenson J, O'Connor M, Lavoie A, Pohlman A, Hall JB (1999) Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 159(2):571–579. https://doi.org/10.1164/ajrccm.159.2.9804127 PubMedCrossRef

89.

Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W (2000) A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 35(1):176–182. https://doi.org/10.1016/S0735-1097(99)00494-5 PubMedCrossRef

90.

Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W (2014) Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging 7(2):265–273. https://doi.org/10.1161/CIRCIMAGING.113.001243 CrossRef

91.

Allan CK (2011) Intensive care of the adult patient with congenital heart disease. Prog Cardiovasc Dis 53(4):274–280. https://doi.org/10.1016/j.pcad.2010.11.002 PubMedCrossRef

92.

Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA (2008) Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 117(18):2320–2328. https://doi.org/10.1161/CIRCULATIONAHA.107.734921 PubMedCrossRef

93.

Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51(3):300–306. https://doi.org/10.1016/j.jacc.2007.09.043 PubMedCrossRef

94.

Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA (2011) Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol 151(3):307–312. https://doi.org/10.1016/j.ijcard.2010.05.066 PubMedCrossRef

95.

Oechslin E (2004) Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 97(Suppl 1):109–115. https://doi.org/10.1016/j.ijcard.2004.08.015 PubMedCrossRef

96.

Van De Bruaene A DM, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiéry JL, Paelinck B, Morissens M, Budts W. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J 2011; Accepted for publication

97.

Tomkiewicz-Pajak L, Hoffman P, Trojnarska O, Lipczynska M, Podolec P, Undas A (2014) Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J Thorac Cardiovasc Surg 147(4):1284–1290. https://doi.org/10.1016/j.jtcvs.2013.06.011 PubMedCrossRef

98.

Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O'Byrne ML, Lin HC, Fogel M, Rome JJ, Rand EB, Russo P, Rychik J, Hepatic Fibrosis I (2017) Universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6(5):e004809. https://doi.org/10.1161/JAHA.116.004809 PubMedPubMedCentralCrossRef

99.

Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in the failing Fontan circulation. Heart 93(5):579–584. https://doi.org/10.1136/hrt.2006.094516 PubMedCrossRef

100.

Rychik J (2016) The relentless effects of the Fontan paradox. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 19(1):37–43. https://doi.org/10.1053/j.pcsu.2015.11.006 PubMedCrossRef

101.

Rychik J (2007) Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2(5):288–300. https://doi.org/10.1111/j.1747-0803.2007.00116.x PubMedCrossRef

102.

Satomi G, Yasukochi S, Harada Y, Takeuchi M (1996) Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation. Heart 76(1):90–91. https://doi.org/10.1136/hrt.76.1.90-b PubMedPubMedCentralCrossRef

103.

Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28(6):535–541. https://doi.org/10.1016/j.healun.2009.02.015 PubMedCrossRef

104.

Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T (2015) Society for Cardiovascular A, Interventions, Heart Failure Society of A, Society for Thoracic S, American Heart A, American College of C. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention). J Card Fail 21(6):499–518. https://doi.org/10.1016/j.cardfail.2015.03.002 PubMedCrossRef

105.

Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N, Morota T, Murakami A, Takamoto S, Kyo S, Ono M (2011) Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 57(3):169–176. https://doi.org/10.1097/MAT.0b013e31820e121c PubMedCrossRef

106.

Menachem JN, Swaminathan AC, Bashore TM, Ward CC, Rogers JG, Milano CA, Patel CB (2015) Initial experience of left ventricular assist device support for adult patients with transposition of the great vessels. Congenit Heart Dis 10(5):382–386. https://doi.org/10.1111/chd.12264 PubMedCrossRef

107.

Stewart AS, Gorman RC, Pocchetino A, Rosengard BR, Acker MA (2002) Left ventricular assist device for right side assistance in patients with transposition. Ann Thorac Surg 74(3):912–914. https://doi.org/10.1016/S0003-4975(02)03671-8 PubMedCrossRef

108.

Joyce DL, Crow SS, John R, St Louis JD, Braunlin EA, Pyles LA, Kofflin P, Joyce LD (2010) Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant 29(11):1302–1305. https://doi.org/10.1016/j.healun.2010.05.030 PubMedCrossRef

109.

Shah NR, Lam WW, Rodriguez FH 3rd, Ermis PR, Simpson L, Frazier OH, Franklin WJ, Parekh DR (2013) Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. J Heart Lung Transplant 32(6):615–620. https://doi.org/10.1016/j.healun.2013.03.003 PubMedCrossRef

110.

Agusala K, Bogaev R, Frazier OH, Franklin WJ (2010) Ventricular assist device placement in an adult with D-transposition of the great arteries with prior Mustard operation. Congenit Heart Dis 5(6):635–637. https://doi.org/10.1111/j.1747-0803.2010.00408.x PubMedCrossRef

111.

VanderPluym C, Urschel S, Buchholz H (2013) Advanced therapies for congenital heart disease: ventricular assist devices and heart transplantation. Can J Cardiol 29(7):796–802. https://doi.org/10.1016/j.cjca.2013.02.008 PubMedCrossRef

112.

Kirk R, Dipchand AI, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbles F, Rahmel AO, Stehlik J, Hertz MI (2012) International Society for H, Lung T. The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report—2012. J Heart Lung Transplant 31(10):1065–1072. https://doi.org/10.1016/j.healun.2012.08.001 PubMedCrossRef

113.

O'Connor MJ, Menteer J, Chrisant MR, Monos D, Lind C, Levine S, Gaynor JW, Hanna BD, Paridon SM, Ravishankar C, Kaufman BD (2010) Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant 29(1):109–116. https://doi.org/10.1016/j.healun.2009.08.028 PubMedCrossRef

114.

Yang J, Schall C, Smith D, Kreuser L, Zamberlan M, King K, Gajarski R (2009) HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. J Heart Lung Transplant 28(2):123–129. https://doi.org/10.1016/j.healun.2008.11.908 PubMedCrossRef

115.

Lewis M, Ginns J, Schulze C, Lippel M, Chai P, Bacha E, Mancini D, Rosenbaum M, Farr M. Outcomes of adult patients with congenital heart disease after heart transplantation: impact of disease type, previous thoracic surgeries, and bystander organ dysfunction. J Card Fail 22(7):578–82. https://doi.org/10.1016/j.cardfail.2015.09.002

116.

Berg CJ, Bauer BS, Hageman A, Aboulhosn JA, Reardon LC (2017) Mortality risk stratification in Fontan patients who underwent heart transplantation. Am J Cardiol 119(10):1675–1679. https://doi.org/10.1016/j.amjcard.2017.02.005 PubMedCrossRef

Titel: Management of acute heart failure in adult patients with congenital heart disease
verfasst von: Alexander Van De Bruaene
Lukas Meier
Walter Droogne
Pieter De Meester
Els Troost
Marc Gewillig
Werner Budts
Publikationsdatum: 25.12.2017
Verlag: Springer US
Erschienen in: Heart Failure Reviews / Ausgabe 1/2018
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-017-9664-x

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Management of acute heart failure in adult patients with congenital heart disease

Abstract

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients

Systematic review of economic burden of heart failure

Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes

De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis

Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie